These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 36613919)

  • 21. Mucolipidoses Overview: Past, Present, and Future.
    Khan SA; Tomatsu SC
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
    Muenzer J
    Mol Genet Metab; 2014 Feb; 111(2):63-72. PubMed ID: 24388732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases.
    Gaffke L; Pierzynowska K; Podlacha M; Brokowska J; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):498-506. PubMed ID: 31855304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and Emerging Therapies for Mucopolysaccharidoses.
    Lagler FB
    Handb Exp Pharmacol; 2020; 261():39-56. PubMed ID: 31451968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.
    Wiesinger AM; Bigger B; Giugliani R; Scarpa M; Moser T; Lampe C; Kampmann C; Lagler FB
    Front Pharmacol; 2022; 13():863667. PubMed ID: 35645812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis.
    Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Piotrowska E; Narajczyk M; Gabig-Cimińska M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac involvement in Lysosomal Storage Diseases.
    Sestito S; Parisi F; Tallarico V; Tarsitano F; Roppa K; Pensabene L; Chimenz R; Ceravolo G; Calabrò MP; De Sarro R; Moricca MT; Bonapace G; Concolino D
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):107-119. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses.
    Safary A; Moghaddas-Sani H; Akbarzadeh-Khiavi M; Khabbazzi A; Rafi MA; Omidi Y
    Expert Opin Biol Ther; 2021 Sep; 21(9):1181-1197. PubMed ID: 33653197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenotonsillar pathology in mucopolysaccharidoses - lysosomal storage predominates in paracortical CD63+ cells.
    Murgasova L; Hulkova H; Baresova V; Jurovcik M; Stritesky J; Jurickova K; Magner M; Sikora J
    Virchows Arch; 2024 Jan; 484(1):135-140. PubMed ID: 37787787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model.
    D'Avanzo F; Zanetti A; Dardis A; Scarpa M; Volpi N; Gatto F; Tomanin R
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs for the treatment of mucopolysaccharidoses.
    Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
    Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses.
    Monaco A; Fraldi A
    Autophagy; 2021 Nov; 17(11):3875-3876. PubMed ID: 34407725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.
    Rintz E; Gaffke L; Podlacha M; Brokowska J; Cyske Z; Węgrzyn G; Pierzynowska K
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucopolysaccharidosis III: Molecular basis and treatment.
    Spahiu L; Behluli E; Peterlin B; Nefic H; Hadziselimovic R; Liehr T; Temaj G
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):201-208. PubMed ID: 34743503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone Remodeling in an Mps-1h Girl after Hematopoietic Stem Cell Transplantation along with Enzymatic Replacement Therapy.
    Tummolo A; Brunetti G; Piacente L; Marzollo A; Biffi A; Burlina A; Faienza MF
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1425-1432. PubMed ID: 35619307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplant outcomes in mucopolysaccharidoses.
    Prasad VK; Kurtzberg J
    Semin Hematol; 2010 Jan; 47(1):59-69. PubMed ID: 20109613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MPSBase: Comprehensive repository of differentially expressed genes for mucopolysaccharidoses.
    Soares LDF; Villalba Silva GC; Kubaski F; Giugliani R; Matte U
    Mol Genet Metab; 2021 Aug; 133(4):372-377. PubMed ID: 34147352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses.
    Wegrzyn G; Wegrzyn A; Tylki-Szymańska A
    Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.